<PAGE> 1
FILED BY PHARMACIA & UPJOHN, INC.
PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933
SUBJECT COMPANY: PHARMACIA & UPJOHN, INC.
COMMISSION FILE NO. 001-11557
On March 28, 2000, Pharmacia & Upjohn, Inc., a Delaware corporation ("Pharmacia
& Upjohn") and Monsanto Company, a Delaware corporation, ("Monsanto"), jointly
issued the following press release:
PHARMACIA CORPORATION TO BEGIN
TRADING AS SOON AS APRIL 3, 2000
ST. LOUIS AND PEAPACK, N.J. (MARCH 28, 2000) - Monsanto Company (NYSE:
MTC) and Pharmacia & Upjohn (NYSE: PNU) today confirmed that they expect their
proposed merger to be completed on or before April 1, 2000, and that the first
day of trading of Pharmacia Corporation will be as soon as April 3, 2000.
Shareholders of Monsanto and Pharmacia & Upjohn approved the merger at
separate shareholder meetings on March 23, 2000. The companies are now awaiting
final clearance of the merger by officials of the European Union.
Pharmacia Corporation will have one of the strongest sales forces in
the global pharmaceutical industry, an expansive product portfolio, a robust new
product pipeline, and an annual pharmaceutical R&D budget of more than $2
billion. Pharmacia Corporation also will have one of the world's leading fully
integrated agricultural businesses.
Pharmacia Corporation's corporate and pharmaceutical business
headquarters will be in Peapack, N.J. The agricultural business headquarters
will be in St. Louis and will retain the Monsanto name.
##
<PAGE> 2
PHARMACIA & UPJOHN MEDIA CONTACT: MONSANTO COMPANY MEDIA CONTACT:
Paul Fitzhenry (908) 901-8770 Scarlett Lee Foster (314) 694-2883
PHARMACIA & UPJOHN ANALYST CONTACT: MONSANTO COMPANY ANALYST CONTACT:
Craig Tooman (908) 901-8853 Ann Gualtieri (847) 581-6280
****************
Monsanto and Pharmacia & Upjohn have filed a definitive joint proxy
statement/prospectus and other relevant documents concerning the merger with the
SEC. WE URGE INVESTORS TO READ THE DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS
AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, BECAUSE THEY CONTAIN
IMPORTANT INFORMATION. Investors will be able to obtain the documents free of
charge at the SEC's Website, www.sec.gov.
In addition, the Form 10-K and other documents filed with the SEC by Monsanto
will be available free of charge from the Secretary of Monsanto at 800 North
Lindbergh Blvd., St. Louis, Missouri 63167, Telephone (314) 694-3155. The Form
10-K and other documents filed with the SEC by Pharmacia & Upjohn will be
available free of charge from the Corporate Secretary of Pharmacia & Upjohn, 100
Route 206 North, Peapack, NJ 07977, Telephone (888) 768-5501. READ THE
DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS CAREFULLY.
